Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

View source ↗

Summary

A clinical trial update evaluating whether the serum B/A ratio is a better early predictor of bilirubin-induced neurologic dysfunction than total serum bilirubi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: alaa aboelhassan mohamed aboelhassan | Conditions: Hyperbilirubinemia, Neonatal | Status: NOT_YET_RECRUITING